Viewing Study NCT06015568


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-01-05 @ 6:17 PM
Study NCT ID: NCT06015568
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-29
First Post: 2023-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module